000 | 01769 a2200493 4500 | ||
---|---|---|---|
005 | 20250513154700.0 | ||
264 | 0 | _c19990225 | |
008 | 199902s 0 0 eng d | ||
022 | _a1078-0432 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFenton, M A | |
245 | 0 | 0 |
_aFunctional characterization of mutant androgen receptors from androgen-independent prostate cancer. _h[electronic resource] |
260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cAug 1997 |
||
300 |
_a1383-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAmino Acid Substitution |
650 | 0 | 4 |
_aAndrogen Antagonists _xpharmacology |
650 | 0 | 4 |
_aAndrogens _xpharmacology |
650 | 0 | 4 |
_aAndrostenedione _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aDihydrotestosterone _xpharmacology |
650 | 0 | 4 |
_aEstradiol _xpharmacology |
650 | 0 | 4 |
_aFlutamide _xanalogs & derivatives |
650 | 0 | 4 | _aGenes, Reporter |
650 | 0 | 4 |
_aImidazoles _xpharmacology |
650 | 0 | 4 | _aImidazolidines |
650 | 0 | 4 |
_aLuciferases _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPoint Mutation |
650 | 0 | 4 |
_aProgesterone _xpharmacology |
650 | 0 | 4 |
_aProstatic Neoplasms _xgenetics |
650 | 0 | 4 |
_aReceptors, Androgen _xbiosynthesis |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xbiosynthesis |
650 | 0 | 4 | _aTransfection |
650 | 0 | 4 |
_abeta-Galactosidase _xgenetics |
700 | 1 | _aShuster, T D | |
700 | 1 | _aFertig, A M | |
700 | 1 | _aTaplin, M E | |
700 | 1 | _aKolvenbag, G | |
700 | 1 | _aBubley, G J | |
700 | 1 | _aBalk, S P | |
773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 3 _gno. 8 _gp. 1383-8 |
|
999 |
_c9780038 _d9780038 |